MYUNGIN PHARM. announces interim cash dividend
명인제약
317450
Signal Score
Historical Avg Return (5d)
-0.35%
Data Coverage
100%n=589
Risk-adjusted indicator based on 589 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
POSITIVE
Key Numbers
- • Dividend per common share: 500 KRW
- • Dividend yield (common shares): 1.2%
- • Total dividend amount: 7.3B KRW
- • Ex-dividend date: August 31, 2026
- • Payment date: September 8, 2026
AI Analysis Summary
MYUNGIN PHARM.CO., LTD. announced an interim cash dividend of 500 KRW per common share, representing a 1.2% dividend yield. The total dividend payout will be 7.3 billion KRW. The ex-dividend date is set for August 31, 2026, with payment scheduled for September 8, 2026. This dividend decision is a positive signal for shareholders, indicating a commitment to shareholder returns.
How This Event Is Evaluated
Dividend Evaluation
Dividend events are evaluated by reviewing shareholder return strength, yield, payout consistency, and changes versus prior periods.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Dividend increase or decrease
- Dividend yield
- Historical consistency
- Payout timing and sustainability
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.